STOCK TITAN

PTC Therapeutics to Participate at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

PTC Therapeutics (NASDAQ: PTCT) announced its participation in two investor conferences. The company will give a presentation at the Bank of America Securities 2002 Healthcare Conference on May 10 at 5:20 p.m. PT and at the 2022 RBC Capital Markets Global Healthcare Conference on May 18 at 2:05 p.m. ET. Both presentations will be available via live webcast on the company's website, with an archive accessible for 30 days post-event. PTC focuses on developing medicines for rare disorders, emphasizing its commitment to patients' unmet medical needs.

Positive
  • None.
Negative
  • None.

SOUTH PLAINFIELD, N.J., April 29, 2022 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company overview at the following conferences:

Bank of America Securities 2002 Healthcare Conference
Tuesday, May 10 at 5:20 p.m. PT

2022 RBC Capital Markets Global Healthcare Conference
Wednesday, May 18 at 2:05 p.m. ET 

The presentation will be webcast live on the Events and Presentations page under the Investor section of PTC Therapeutics' website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection.

About PTC Therapeutics, Inc.
PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need. The company's strategy is to leverage its strong scientific expertise and global commercial infrastructure to maximize value for its patients and other stakeholders. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Instagram, Facebook, Twitter, and LinkedIn.

For More Information:

Investors:
Kylie O'Keefe
+1 (908) 300-0691
kokeefe@ptcbio.com

Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com

Cision View original content:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-at-upcoming-investor-conferences-301536446.html

SOURCE PTC Therapeutics, Inc.

FAQ

When will PTC Therapeutics present at the Bank of America Securities Healthcare Conference?

PTC Therapeutics will present at the Bank of America Securities 2002 Healthcare Conference on May 10, 2022, at 5:20 p.m. PT.

What time is PTC Therapeutics' presentation at the RBC Capital Markets Global Healthcare Conference?

The presentation by PTC Therapeutics at the RBC Capital Markets Global Healthcare Conference is scheduled for May 18, 2022, at 2:05 p.m. ET.

Where can I watch the PTC Therapeutics presentations live?

The presentations by PTC Therapeutics can be watched live on the Events and Presentations page of their website.

How long will the PTC Therapeutics presentations be available for viewing after the events?

The webcasts of the PTC Therapeutics presentations will be archived for 30 days following the events.

What is the focus of PTC Therapeutics as a biopharmaceutical company?

PTC Therapeutics focuses on the discovery, development, and commercialization of medicines for patients with rare disorders.

PTC Therapeutics, Inc.

NASDAQ:PTCT

PTCT Rankings

PTCT Latest News

PTCT Stock Data

3.39B
77.13M
2.34%
105.79%
6.06%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
WARREN